Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: A review of evidence

European Journal of Cardio-thoracic Surgery

Volumn 25, Issue 3, 2004, Pages 304-311

  Anselmi, Amedeo ^a   Abbate, Antonio ^b   Girola, Fabiana ^b   Nasso, Giuseppe ^b   Biondi Zoccai, Giuseppe G L ^b   Possati, Gianfederico ^b   Gaudino, Mario ^b,c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Apoptosis; Cardiac surgery; Cardiopulmonary bypass; Inflammation

Indexed keywords

ANTIOXIDANT; BIOCHEMICAL MARKER; CASPASE 3; CASPASE 9; CD11B ANTIGEN; CD31 ANTIGEN; CITRATE SYNTHASE; CREATINE KINASE; CYTOCHROME C; DEFEROXAMINE; DNA FRAGMENT; EBSELEN; FAS LIGAND; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE; MESSENGER RNA; PADGEM PROTEIN; PROTEIN BAX; PURINE DERIVATIVE; PYRUVIC ACID; THROMBOXANE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; EXTRACORPOREAL CIRCULATION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART SURGERY; HUMAN; MOLECULAR MECHANICS; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REVIEW; STUNNED HEART MUSCLE; TREATMENT OUTCOME;

APOPTOSIS; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; HUMANS; INTRAOPERATIVE COMPLICATIONS; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; MYOCARDITIS;

EID: 1542613966     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2003.12.003     Document Type: Review

References (65)

1. Paparella D., Yau T.M., Young E. Cardiopulmonary bypass induces inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 21:2002;232-244.
2. Zahler S., Massoudy P., Hartl H., Hahnel C., Meisner H., Becker B.F. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res. 41:1999;722-730.
3. Baufreton C., Intrator L., Jansen P., te Velthuis H., Le Besnerais P., Vonk A., Farcet J.P., Wildevuur C., Loisance D.Y. Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. Ann Thorac Surg. 67:1999;972-977.
4. Bolli R., Marbàn E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 79:1999;609-634.
5. Appleyard R.F., Cohn L.H. Myocardial stunning and reperfusion injury in cardiac surgery. J Card Surg. 8:1993;316-324.
6. Luss H., Schäfers M., Neumann J., Hammel D., Vahlhaus C., Baba H.A., Janssen F., Scheld H.H., Schober O., Breithardt G., Schmitz W., Wichter T. Biochemical mechanisms of hibernation and stunning in the human heart. Cardiovasc Res. 56:2002;411-421.
7. Saraste A. Morphologic criteria and detection of apoptosis. Herz. 24:1999;189-195.
8. Abbate A., Biondi-Zoccai G., Baldi A. Pathophysiological role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol. 193:2002;145-153.
9. Abbate A., Biondi-Zoccai G., Petrolini A., Biasucci L.M., Baldi A. Clinical relevance of apoptosis in early and late post-infarction left ventricular remodeling. Ital Heart J. 3:2002;699-705.
10. Wan S., Yim A. Cytokines in myocardial injury: impact on cardiac surgical approach. Eur J Cardiothorac Surg. 16:(1):1999;S107-S111.
11. te Velthius H., Jansen P.G., Oudemans-van Straaten H.M., Sturk A., Eijsman L., Wildevuur C.R. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. J Thorac Cardiovasc Surg. 110:1995;1663-1669.
12. Krown K.A., Page M.T., Nguyen C., Zechner D., Gutierrez V., Comstock K.L., Glembotski C.C., Quintana P.J., Sabbadini R.A. Tumor necrosis factor alpha-induced apoptosis in cardiac myocites: involvement of the sphingolipid-signaling cascade in cardiac cell death. J Clin Invest. 98:1996;2854-2865.
13. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol. 274:1998;R577-R595.
14. Westhuyzen J., Cochrane A.D., Tesar P.J., Mau T., Cross D.B., Frenneaux M.P., Khafagi F.A., Fleming S.J. Effective of preoperative supplementation with α-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations. J Thorac Cardiovasc Surg. 113:1997;942-948.
15. Yau T.M., Weisel R.D., Mickle D.A., Burton G.W., Ingold K.U., Ivanov J., Mohabeer M.K., Tumiati L., Carson S. Vitamin E for coronary bypass operations. A prospective, double blind, randomized trial. J Thorac Cardiovasc Surg. 108:1994;302-310.
16. Vento A.E., Aittomaki J., Verkkala K.A., Heikkila L.J., Salo J.A., Sipponen J., Ramo O.J. Nitecapone as an additive to crystalloid cardioplegia in patients who had coronary artery bypass grafting. Ann Thorac Surg. 68:1999;413-420.
17. Pesonen E.J., Vento A.E., Ramo O.J., Vuorte J., Jansson S.E., Repo H. Nitecapone reduces cardiac neutrophil accumulation in clinical open heart surgery. Anesthesiology. 91:1999;355-361.
18. Butterworth J., Legault C., Stump D.A., Coker L., Hammon J.W. Jr., Troost B.T., Royster R.L., Prough D.S. A randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 13:1999;690-694.
19. Wan S., Yim A., Wong C.K., Arifi A.A., Yip J.H., Ng C.S., Waye M.M., Lam C.W. Expression of FHL2 and cytokine messenger RNAs in human myocardium after cardiopulmonary bypass. Int J Cardiol. 86:2002;265-272.
20. Scholl F.A., McLoughlin P., Ehler E., de Giovanni C., Schafer B.W. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J Cell Biol. 151:2000;495-506.
21. Schmitt J.P., Schroder J., Schunkert H., Birnbaum D.E., Aebert H. Role of apoptosis in myocardial stunning after open-heart surgery. Ann Thorac Surg. 73:2002;1229-1235.
22. Zorc M., Vraspir-Porenta O., Zorc-Pleskovic R., Radovanovic N., Petrovic D. Apoptosis of myocites and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy. Cardiovasc Pathol. 12:2003;36-39.
23. Aebert H., Kirchner S., Keyser A., Birnbaum D.E., Holler E., Andreesen R., Eissner G. Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg. 18:2000;589-593.
24. Birdi I., Angelini G.D., Bryan A.J. Biochemical markers of myocardial injury during cardiac operations. Ann Thorac Surg. 63:1997;879-884.
25. Joashi U., Tibby S.M., Turner C., Mayer A., Austin C., Anderson D., Durward A., Murdoch I.A. Soluble Fas may be a proinflammatory marker after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg. 123:2002;137-144.
26. Vallbracht K.B., Schwimmbeck P.L., Seeberg B., Kuhl U., Schultheiss H.P. Endothelial dysfunction of peripheral arteries in patients with immunohistologically confirmed myocardial inflammation correlates with endothelial expression of human leukocyte antigen and adhesion molecules in myocardial biopsies. J Am Coll Cardiol. 40:2002;515-520.
27. Rajesh S., Sasaguri S., Tian Z.Z., Asakai R. Potential role of mitochondrial permeability transition pore following long-time hypothermic heart preservation. Transplant Proc. 34:2002;2645-2646.
28. Javadov S.A., Lim K., Kerr P.M., Suleiman M.S., Angelini G.D., Halestrap A.P. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res. 45:2000;360-369.
29. McCully J.D., Wakiyama H., Cowan D.B., Federman M., Parker R.A., Levitsky S. Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery. Ann Thorac Surg. 74:2002;2138-2146.
30. Wakaiyama H., Cowan D.B., Toyoda Y., Federman M., Levitsky S., McCully J.D. Selective opening of mitochondrial ATP-sensitive potassium channels during surgically induced myocardial ischemia decreases necrosis and apoptosis. Eur J Cardiothorac Surg. 21:2002;424-433.
31. Toyoda Y., Levitsky S., McCully J.D. Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection. Ann Thorac Surg. 71:2001;1281-1289.
32. Maulik N., Yoshida T. Oxidative stress developed during open heart surgery induces inflammation: reduction of apoptotic cell death by ebselen, a glutathione peroxidase mimic. J Cardiovasc Pharmacol. 36:2000;601-608.
33. Dobsak P., Siegelova J., Wolf J.E., Rochette L., Eicher J.C., Vasku J., Kuchtickova S., Horky M. Prevention of apoptosis by deferoxamine during 4 hours of cold cardioplegia and reperfusion: in vitro study of isolated working rat heart model. Pathophysiology. 9:2002;27-32.
34. Maulik N., Yoshida T., Das K.D. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med. 24:1998;869-875.
35. Vazquez-Jimenez J.F., Qing M., Hermanns B., Klosterhalfen B., Woltje M., Chakupurakal R., Schumacher K., Messmer B.J., von Bernuth G., Seghaye M.C. Moderate hypothermia during cardiopulmonary bypass reduces myocardial cell damage and myocardial cell death related to cardiac surgery. J Am Coll Cardiol. 38:2001;1216-1223.
36. Qing M., Vazquez-Jimenez J.F., Schumacher K., Bhardwaj R.S., Klosterhalfen B., Minkenberg R., Messmer B.J., von Bernuth G., Seghaye M.C. Moderate hypothermia during cardiopulmonary bypass increases intramyocardial synthesis of heat shock protein 72. J Thorac Cardiovasc Surg. 124:2002;724-731.
37. Ning X.H., Xu C.S., Portman M.A. Mitochondrial protein and HSP-70 signaling after ischemia in hypothermic-adapted hearts augmented with glucose. Am J Physiol. 277:(1 Pt 2):1999;R11-R17.
38. Baan C.C., Balk A.H., van Riemsdijk I.C., Vantrimpont P.J., Maat A.P., Niesters H.G., Zondervan P.E., van Gelder T., Weimar W. Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation. Transplantation. 75:2003;1704-1710.
39. Birdi I., Caputo M., Underwood M., Bryan A.J., Angelini G.D. The effects of cardiopulmonary bypass temperature on inflammatory response following cardiopulmonary bypass. Eur J Cardiothorac Surg. 16:1999;540-545.
40. Ascione A., Caputo M., Gomes W.J., Lotto A.A., Bryan A.J., Angelini G.D., Suleiman M.S. Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm cardioplegia. Eur J Cardiothorac Surg. 21:2002;440-446.
41. Aebert H., Cornelius T., Birnbaum D.E., Siegel A.V., Riegger G.A., Schunkert H. Induction of early immediate genes and programmed cell death following cardioplegic arrest in human hearts. Eur J Cardiothorac Surg. 12:(2):1997;261-267.
42. Bolli R., Hartley C.J., Rabinovitz R.S. Clinical relevance of myocardial stunning. Cardiovasc Drugs Ther. 5:1991;877-890.
43. Carlucci F., Tabucchi A., Biagioli B., Simeone F., Scolletta S., Rosi F., Marinello E. Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia-reperfusion. Biomed Pharmacother. 56:2002;483-491.
44. Dobsak P., Courderot-Masuyer C., Zeller M., Vergely C., Laubriet A., Assem M., Eicher J.C., Teyssier J.R., Wolf J.E., Rochette L. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol. 34:1999;651-659.
45. Drabe N., Zund G., Grunenfelder J., Sprenger M., Hoerstrup S.P., Bestmann L., Maly F.E., Turina M. Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines. Eur J Cardiothorac Surg. 20:2001;609-613.
46. Eberhardt F., Mehlhorn U., Larose K., De Vivie R., Dhein S.H. Structural myocardial changes after coronary artery surgery. Eur J Clin Invest. 30:2000;938-946.
47. Gaudino M., Nasso G., Zamparelli R., Andreotti F., Burzotta F., Iacoviello L., Santarelli F., Lapenna E., Bruno P., Di Pietrantonio F., Schiavello R., Maseri A., Possati G. Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation. Ital Heart J. 3: (6 Suppl):2002;646-651.
48. Hammel J.M., Caldarone C.A., Van Natta T.L., Wang L.X., Welke L.F., Li W., Niles S., Barner E., Scholz T.D., Behrendt D.M., Segar J.L. Myocardial apoptosis after cardioplegic arrest in the neonatal lamb. J Thorac Cardiovasc Surg. 125:2003;1268-1275.
49. Hill G.E., Springall D.R., Robbins R.A. Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass. Surgery. 121:1997;449-455.
50. Kilger E., Weis F., Briegel J., Frey L., Goetz A.E., Reuter D., Nagy A., Schuetz A., Lamm P., Knoll A., Klaus P. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med. 31:2003;1068-1074.
51. Krijnen P.A., Nijmeijer R., Mijer C.J., Visser C.A., Hack C.E., Niessen H.W. Apoptosis in myocardial ischemia and infarction. J Clin Pathol. 55:2002;801-811.
52. Massoudy P., Zahler S., Freyholdt T., Henze R., Barankay A., Becker B.F., Braun S.L., Meisner H. Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances. J Thorac Cardiovasc Surg. 119:2000;566-574.
53. Pruefer D., Buerke U., Khalil M., Dahm M., Darius H., Oelert H., Buerke M. Cardioprotective effect of the serine protease aprotinin after regional ischemia and reperfusion in the beating heart. J Thorac Cardiovasc Surg. 124:2002;942-949.
54. Remondino A., Kwon S.H., Communal C., Pimentel D.R., Sawyer D.B., Singh K., Colucci W.S. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res. 92:2003;136-138.
55. Ruetten H., Badorff C., Ihling C., Dahm M., Darius H., Oelert H., Buerke M. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects. J Am Coll Cardiol. 38:2001;2063-2070.
56. Sato H., Zhao Z.Q., Jordan J.E., Todd J.C., Riley R.D., Taft C.S., Hammon J.W. Jr., Li P., Ma X., Vinten-Johansen J. Basal nitric oxide expresses endogenous cardioprotection during reperfusion by inhibition of neutrophil-mediated damage after surgical revascularization. J Thorac Cardiovasc Surg. 113:1997;399-409.
57. Scheubel R.J., Bartling B., Simm A., Silber R.E., Drogaris K., Darmer D., Holtz J. Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium. J Am Coll Cardiol. 39:2002;481-488.
58. Schmitt J.P., Schunkert H., Dirnbaum D.E., Aebert H. Kinetics of heat shock protein 70 synthesis in the human heart after cold cardioplegic arrest. Eur J Cardiothorac Surg. 22:2002;415-420.
59. Stadler B., Phillips J., Toyoda Y., Federman M., Levitsky S., McCully J.D. Adenosine-enhanced ischemic preconditioning modulates necrosis and apoptosis: effects of stunning and ischemia-reperfusion. Ann Thorac Surg. 72:2001;555-564.
60. Stammberger U., Gaspert A., Hillinger S., Vogt B., Odermatt B., Weder W., Schmid R.A. Apoptosis induced by ischemia and reperfusion during experimental lung transplantation. Ann Thorac Surg. 69:2000;1532-1536.
61. Suleiman M.S., Halestrap A.T., Griffiths E.J. Mitochondria: a target for myocardial protection. Pharmacol Ther. 89:2001;29-46.
62. Videm V., Mollnes T.E., Bergh K., Fosse E., Mohr B., Hagve T.A., Aasen A.O., Svennevig J.L. Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo. J Thorac Cardiovasc Surg. 117:1999;803-809.
63. Vinten-Johansen J., Thourani V.H., Ronson R.S., Jordan J.E., Zhao Z.Q., Nakamura M., Velez D., Guyton R.A. Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg. 68:1999;1942-1948.
64. Yeh C.H., Wang Y.C., Wu Y.C., Chu J.J., Lin P.J. Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocyte apoptosis. Chest. 123:2003;1647-1654.
65. Zhao Z.Q., Morris C.D., Buddle J.M., Wang N.P., Muraki S., Sun H.Y., Guyton R.A. Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovasc Res. 59:2003;132-142.